2-(2-CHLORO-3-PYRIDINYL)-1,3-BENZOXAZOLE
- $362 - $1040
- Product name: 2-(2-CHLORO-3-PYRIDINYL)-1,3-BENZOXAZOLE
- CAS: 134673-71-5
- MF: C12H7ClN2O
- MW: 230.65
- EINECS:
- MDL Number:MFCD08689672
- Synonyms:2-(2-CHLORO-3-PYRIDINYL)-1,3-BENZOXAZOLE;Benzoxazole, 2-(2-chloro-3-pyridinyl)-
5 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM309815
- Product description2-(2-Chloropyridin-3-yl)benzo[d]oxazole 95%
- Packaging5g
- Price$608
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11289998
- Product description2-(2-Chloropyridin-3-yl)benzo[d]oxazole 95+%
- Packaging5g
- Price$644
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number046845
- Product description2-(2-Chloro-3-pyridinyl)-1,3-benzoxazole >95%
- Packaging500mg
- Price$362
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number046845
- Product description2-(2-Chloro-3-pyridinyl)-1,3-benzoxazole >95%
- Packaging1g
- Price$454
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number046845
- Product description2-(2-Chloro-3-pyridinyl)-1,3-benzoxazole >95%
- Packaging5g
- Price$1040
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM309815 | 2-(2-Chloropyridin-3-yl)benzo[d]oxazole 95% | 5g | $608 | 2021-12-16 | Buy |
Crysdot | CD11289998 | 2-(2-Chloropyridin-3-yl)benzo[d]oxazole 95+% | 5g | $644 | 2021-12-16 | Buy |
Matrix Scientific | 046845 | 2-(2-Chloro-3-pyridinyl)-1,3-benzoxazole >95% | 500mg | $362 | 2021-12-16 | Buy |
Matrix Scientific | 046845 | 2-(2-Chloro-3-pyridinyl)-1,3-benzoxazole >95% | 1g | $454 | 2021-12-16 | Buy |
Matrix Scientific | 046845 | 2-(2-Chloro-3-pyridinyl)-1,3-benzoxazole >95% | 5g | $1040 | 2021-12-16 | Buy |
Properties
Melting point :94-95°C
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|